Welcome, Guest

 or  Register

"Goldman Sachs: Curing Cancer is ‘NOT a Sustainable Business Model’"

"Treating sick people is far more profitable than curing them, according to Goldman Sachs.

"One of the largest banks in the world, Goldman Sachs, has declared that curing patients of cancer, and other terminal illnesses, is not a “sustainable business model.”

The global investment firm also urged investors to resist financing pioneering “gene therapy” treatments as developing cures is bad for business “in the long-term.”

Goldman Sachs advises investors against funding cures

Goldman Sachs sent the “advice” to their clients and investors in an April 10 report.

Entitled “The Genome Revolution,” the world’s 5th largest bank asks: “Is curing patients a sustainable business model?”

Analyst Salveen Richter wrote in the note that long-term treatments garner far more revenue than “one-shot cures,” saying:

“The potential to deliver ‘one-shot cures’ is one of the most attractive aspects of gene therapy, genetically-engineered cell therapy, and gene editing.

“However, such treatments offer a very different outlook with regard to recurring revenue versus chronic therapies.

“While this proposition carries tremendous value for patients and society, it could represent a challenge for genome medicine developers looking for sustained cash flow.”

Goldman Sachs: Curing Cancer is 'NOT a Sustainable Business Model'

The report states that developing cures is ‘bad for business’

According to CNBC, Richter cited Gilead Sciences’ treatments for hepatitis C, which achieved cure rates of more than 90 percent.

The company’s U.S. sales for these hepatitis C treatments peaked at $12.5 billion in 2015, but have been falling ever since.

Long-term treatments equate to long-term profits

Goldman Sachs estimates the U.S. sales for these treatments will be less than $4 billion this year, according to a table in the report.

“GILD is a case in point, where the success of its hepatitis C franchise has gradually exhausted the available pool of treatable patients,” the analyst wrote.

“In the case of infectious diseases such as hepatitis C, curing existing patients also decreases the number of carriers able to transmit the virus to new patients, thus the incident pool also declines…

“Where an incident pool remains stable (eg, in cancer) the potential for a cure poses less risk to the sustainability of a franchise.”

The analyst didn’t immediately respond to a request for comment. ..."


Romans 10:9-10
atabrigade, JF Priest, Sassy  likes this!
Reply Share
They are no longer human.
"Here they defended themselves to the last, those who still had swords using them, and the others resisting with their hands and teeth."Herodotus VII, 225
BirdLady2, Sassy  likes this!
Reply Share
Were They ever ?
Celebrating Over 30 Years as a " Designated Paper Terrorist " - I Will Stand Corrected - No Legal Advice or Recommended Course of Action Expressed or Implied

The Constitution - Estate in Trust for the Heirs of Freedom - Local Link
BirdLady2  likes this!
Reply Share